341 related articles for article (PubMed ID: 34991665)
1. The CD70-CD27 axis in oncology: the new kids on the block.
Flieswasser T; Van den Eynde A; Van Audenaerde J; De Waele J; Lardon F; Riether C; de Haard H; Smits E; Pauwels P; Jacobs J
J Exp Clin Cancer Res; 2022 Jan; 41(1):12. PubMed ID: 34991665
[TBL] [Abstract][Full Text] [Related]
2. CD70 expression correlates with a worse prognosis in malignant pleural mesothelioma patients via immune evasion and enhanced invasiveness.
Inaguma S; Lasota J; Czapiewski P; Langfort R; Rys J; Szpor J; Waloszczyk P; OkoĊ K; Biernat W; Schrump DS; Hassan R; Kasai K; Miettinen M; Ikeda H
J Pathol; 2020 Feb; 250(2):205-216. PubMed ID: 31639216
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of prognosis and immune function of CD70-CD27 signaling axis in pan-cancer.
Kong F; Ye Q; Xiong Y
Funct Integr Genomics; 2023 Jan; 23(1):48. PubMed ID: 36700974
[TBL] [Abstract][Full Text] [Related]
4. CD70 expression in tumor-associated fibroblasts predicts worse survival in colorectal cancer patients.
Inoue S; Ito H; Tsunoda T; Murakami H; Ebi M; Ogasawara N; Kasugai K; Kasai K; Ikeda H; Inaguma S
Virchows Arch; 2019 Oct; 475(4):425-434. PubMed ID: 30980190
[TBL] [Abstract][Full Text] [Related]
5. CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment.
Seyfrid M; Maich WT; Shaikh VM; Tatari N; Upreti D; Piyasena D; Subapanditha M; Savage N; McKenna D; Mikolajewicz N; Han H; Chokshi C; Kuhlmann L; Khoo A; Salim SK; Archibong-Bassey B; Gwynne W; Brown K; Murtaza N; Bakhshinyan D; Vora P; Venugopal C; Moffat J; Kislinger T; Singh S
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35017149
[TBL] [Abstract][Full Text] [Related]
6. Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM.
Ge H; Mu L; Jin L; Yang C; Chang YE; Long Y; DeLeon G; Deleyrolle L; Mitchell DA; Kubilis PS; Lu D; Qi J; Gu Y; Lin Z; Huang J
Int J Cancer; 2017 Oct; 141(7):1434-1444. PubMed ID: 28612394
[TBL] [Abstract][Full Text] [Related]
7. Targeting the CD27-CD70 Pathway to Improve Outcomes in Both Checkpoint Immunotherapy and Allogeneic Hematopoietic Cell Transplantation.
Lutfi F; Wu L; Sunshine S; Cao X
Front Immunol; 2021; 12():715909. PubMed ID: 34630390
[TBL] [Abstract][Full Text] [Related]
8. Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy.
Nagato T; Komatsuda H; Hayashi R; Takahara M; Kishibe K; Yasuda S; Yajima Y; Kosaka A; Ohkuri T; Oikawa K; Harabuchi S; Kono M; Yamaki H; Wakisaka R; Hirata-Nozaki Y; Ohara K; Kumai T; Katada A; Hayashi T; Harabuchi Y; Kobayashi H
Cancer Immunol Immunother; 2023 Jul; 72(7):2087-2098. PubMed ID: 36811663
[TBL] [Abstract][Full Text] [Related]
9. CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies.
Al Sayed MF; Ruckstuhl CA; Hilmenyuk T; Claus C; Bourquin JP; Bornhauser BC; Radpour R; Riether C; Ochsenbein AF
Blood; 2017 Jul; 130(3):297-309. PubMed ID: 28495792
[TBL] [Abstract][Full Text] [Related]
10. CD70 Inversely Regulates Regulatory T Cells and Invariant NKT Cells and Modulates Type 1 Diabetes in NOD Mice.
Ye C; Low BE; Wiles MV; Brusko TM; Serreze DV; Driver JP
J Immunol; 2020 Oct; 205(7):1763-1777. PubMed ID: 32868408
[TBL] [Abstract][Full Text] [Related]
11. CD70 Activation Decreases Pulmonary Fibroblast Production of Extracellular Matrix Proteins.
Tran-Nguyen TK; Xue J; Feghali-Bostwick C; Sciurba FC; Kass DJ; Duncan SR
Am J Respir Cell Mol Biol; 2020 Aug; 63(2):255-265. PubMed ID: 32320626
[TBL] [Abstract][Full Text] [Related]
12. ARGX-110, a highly potent antibody targeting CD70, eliminates tumors via both enhanced ADCC and immune checkpoint blockade.
Silence K; Dreier T; Moshir M; Ulrichts P; Gabriels SM; Saunders M; Wajant H; Brouckaert P; Huyghe L; Van Hauwermeiren T; Thibault A; De Haard HJ
MAbs; 2014; 6(2):523-32. PubMed ID: 24492296
[TBL] [Abstract][Full Text] [Related]
13. T cells redirected against CD70 for the immunotherapy of CD70-positive malignancies.
Shaffer DR; Savoldo B; Yi Z; Chow KK; Kakarla S; Spencer DM; Dotti G; Wu MF; Liu H; Kenney S; Gottschalk S
Blood; 2011 Apr; 117(16):4304-14. PubMed ID: 21304103
[TBL] [Abstract][Full Text] [Related]
14. Increased CD8
Zhao S; Zhang Y; Huang G; Luo W; Li Y; Xiao Y; Zhou M; Li Y; Lai J; Li Y; Li B
Blood Cells Mol Dis; 2019 Jul; 77():34-42. PubMed ID: 30953940
[TBL] [Abstract][Full Text] [Related]
15. CD70-mediated CD27 expression downregulation contributed to the regulatory B10 cell impairment in rheumatoid arthritis.
Shi L; Hu F; Zhu L; Xu C; Zhu H; Li Y; Liu H; Li C; Liu N; Xu L; Mu R; Li Z
Mol Immunol; 2020 Mar; 119():92-100. PubMed ID: 32006824
[TBL] [Abstract][Full Text] [Related]
16. Plasma CD27, a Surrogate of the Intratumoral CD27-CD70 Interaction, Correlates with Immunotherapy Resistance in Renal Cell Carcinoma.
Benhamouda N; Sam I; Epaillard N; Gey A; Phan L; Pham HP; Gruel N; Saldmann A; Pineau J; Hasan M; Quiniou V; Nevoret C; Verkarre V; Libri V; Mella S; Granier C; Broudin C; Ravel P; De Guillebon E; Mauge L; Helley D; Jabla B; Chaput N; Albiges L; Katsahian S; Adam J; Mejean A; Adotevi O; Vano YA; Oudard S; Tartour E
Clin Cancer Res; 2022 Nov; 28(22):4983-4994. PubMed ID: 36067339
[TBL] [Abstract][Full Text] [Related]
17. Osteoclast precursors in murine bone marrow express CD27 and are impeded in osteoclast development by CD70 on activated immune cells.
Xiao Y; Song JY; de Vries TJ; Fatmawati C; Parreira DB; Langenbach GE; Babala N; Nolte MA; Everts V; Borst J
Proc Natl Acad Sci U S A; 2013 Jul; 110(30):12385-90. PubMed ID: 23832783
[TBL] [Abstract][Full Text] [Related]
18. CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells.
Arroyo Hornero R; Georgiadis C; Hua P; Trzupek D; He LZ; Qasim W; Todd JA; Ferreira RC; Wood KJ; Issa F; Hester J
Commun Biol; 2020 Jul; 3(1):375. PubMed ID: 32665635
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of CD70 expression on T cells in human T-lymphotropic virus type-1 carriers and adult T cell leukemia/ lymphoma patients.
Masamoto I; Yoshimitsu M; Kuroki A; Horai S; Ezinne CC; Kozako T; Hachiman M; Kamada Y; Baba M; Arima N
Leuk Lymphoma; 2016; 57(3):685-91. PubMed ID: 26077361
[TBL] [Abstract][Full Text] [Related]
20. Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection.
Izawa K; Martin E; Soudais C; Bruneau J; Boutboul D; Rodriguez R; Lenoir C; Hislop AD; Besson C; Touzot F; Picard C; Callebaut I; de Villartay JP; Moshous D; Fischer A; Latour S
J Exp Med; 2017 Jan; 214(1):73-89. PubMed ID: 28011863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
